Načítá se...
1α,25-dihydroxyvitamin D(3) promotes osseointegration of titanium implant via downregulating AGEs/RAGE pathway in T2DM
Diabetes-induced advanced glycation end products (AGEs) overproduction would result in compromised osseointegration of titanium implant and high rate of implantation failure. 1α,25-dihydroxyvitamin D(3) (1,25VD(3)) plays a vital role in osteogenesis, whereas its effects on the osseointegration and t...
Uloženo v:
| Vydáno v: | Endocr Connect |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bioscientifica Ltd
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215803/ https://ncbi.nlm.nih.gov/pubmed/30352411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0241 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|